Sign In
Buy PET
$0.0469
+0 (+0%)
At Close: Oct 28, 2025
Grey Matters Health to open first NovaScan Neuroimaging Clinic in September
08:39am, Tuesday, 04'th Aug 2026
Grey Matters Health (CSE:GREY, OTCQB:AGNPD, FRA:AGW0) announced that it will be opening its first NovaScan Neuroimaging Clinic in September, marking the start of the company's planned US expansion foc
Grey Matters Announces September Opening of its First Brain Dedicated PET Neuroimaging Clinic in the U.S.
07:00am, Tuesday, 04'th Aug 2026
VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare comp
[url="]Ionis Pharmaceuticals, Inc.[/url] (Nasdaq: IONS) today announced that its partner, Biogen, shared data from the Phase 2 CELIA study evaluating diranerse
Grey Matters Health expands brain imaging services – ICYMI
09:10am, Saturday, 11'th Jul 2026
Grey Matters Health (CSE:GREY, OTCQB:AGNPD, FRA:AGW0) earlier this week announced the arrival of its dedicated brain PET scanning system at the company's flagship clinic in Davie, Florida, representin
Grey Matters Health takes delivery of first brain-dedicated PET scanner for Florida clinic
09:21am, Monday, 06'th Jul 2026
Grey Matters Health (CSE:GREY, OTCQB:AGNPD, FRA:AGW0) announced that it has taken delivery of its first brain-dedicated positron emission tomography (PET) scanner for its NovaScan Neuroimaging Clinics
VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare comp
Pet Valu Holdings Ltd. (PET) Closes the Market
05:13pm, Tuesday, 23'rd Jun 2026
Toronto, Ontario--(Newsfile Corp. - June 23, 2026) - Greg Ramier, Chief Executive Officer, Pet Valu Holdings Ltd. ("Pet Valu" or the "Company") (TSX: PET), joined Dani Lipkin, Managing Director, Globa
Yellowbird Diagnostics Completes Dosing in First-in-Human Phase 1 Trial of NeuCaVis(TM)
07:51am, Monday, 22'nd Jun 2026
Human data demonstrates translation of key findings from preclinical studies Novel F18 PET imaging agent designed to identify inflammation. Program advancing toward Phase 2 patient studies Ottawa, Ont
GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations
09:00am, Monday, 01'st Jun 2026
As theranostics adoption acceleratesi and radiopharmaceutical demand grows,ii healthcare systems are under increasing pressure to scale nuclear medicine operat
AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS
07:00am, Friday, 22'nd May 2026
AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS Presentation at 2026 TDP43 Summit shows ACI-19626 detects TDP-43 pathology in patients
VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare com
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
06:30am, Friday, 15'th May 2026
MELBOURNE, Australia and INDIANAPOLIS, May 15, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that it has entered into letters of intent to
Pet Valu Announces Election of Directors
08:48pm, Tuesday, 12'th May 2026
MARKHAM, Ontario, May 12, 2026 (GLOBE NEWSWIRE) -- Pet Valu Holdings Ltd. (“Pet Valu” or the “Company”) (TSX: PET) announced at its Annual General Meeting of Shareholders (the “Meeting”) h
Pet Valu Holdings Ltd. (PET:CA) Shareholder/Analyst Call Prepared Remarks Transcript
04:50pm, Tuesday, 12'th May 2026
Pet Valu Holdings Ltd. (PET:CA) Shareholder/Analyst Call Prepared Remarks Transcript
Pet Valu Holdings Ltd. (PET:CA) Q1 2026 Earnings Call Transcript
01:10pm, Tuesday, 12'th May 2026
Pet Valu Holdings Ltd. (PET:CA) Q1 2026 Earnings Call Transcript
